PATENT CLAIM ANALYSIS

Application Number: 15768648
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-02
Patent Classification: ["514", "252110"]

Abstract:
Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of treating or preventing fibrosis and compounds for use in such methods are described.

Claim (Index 38):
A method of inhibiting SRPK1 to thereby treat or prevent a disease or condition in a subject in need thereof, said method comprising administering a therapeutically effective amount of a SRPK1-specific inhibitor compound according to  claim 20  to said subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.53571
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15304678', '15708315', '14488601', '13059659', '10590026']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7468740151410941
- 35 USC 102 Novelty (BERT): 0.5361149039498678
- Combined Prediction Score: 0.7257981040219715
- Mean Citation Score: 329.7354660000001
- Max Citation Score: 353.65442
- Similarity Product: 244.1573216690064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test